Catalyst Pharm Inc
(CPRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 689,892 | 652,800 | 580,656 | 517,553 | 442,331 |
| Receivables | 106,409 | 65,863 | 71,265 | 65,476 | 58,266 |
| Inventories | 28,029 | 18,650 | 19,778 | 19,541 | 20,017 |
| TOTAL | $852,453 | $758,739 | $685,718 | $623,609 | $538,998 |
| Non-Current Assets | |||||
| PPE Net | 1,077 | 1,149 | 1,239 | 1,354 | 1,380 |
| Investments And Advances | 19,167 | 21,256 | 24,208 | 21,564 | 14,842 |
| Intangibles | 128,639 | 137,983 | 147,327 | 156,672 | 166,016 |
| Other Non-Current Assets | 50,266 | 52,788 | 50,380 | 48,212 | 50,774 |
| TOTAL | $199,149 | $213,176 | $223,154 | $227,802 | $233,012 |
| Total Assets | $1,051,602 | $971,915 | $908,872 | $851,411 | $772,010 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,096 | 5,528 | 11,197 | 16,593 | 11,563 |
| Accrued Expenses | 119,639 | 107,479 | 100,452 | 104,085 | 93,832 |
| TOTAL | $128,735 | $113,007 | $111,649 | $120,678 | $105,395 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 2,622 | 2,881 | 2,940 | 3,101 | 5,674 |
| TOTAL | $2,622 | $2,881 | $2,940 | $3,101 | $5,674 |
| Total Liabilities | $131,357 | $115,888 | $114,589 | $123,779 | $111,069 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 122,912 | 122,391 | 121,975 | 121,450 | 119,273 |
| Common Shares | 123 | 122 | 122 | 121 | 119 |
| Retained earnings | 446,789 | 394,006 | 341,898 | 285,161 | 229,225 |
| Other shareholders' equity | 0 | 31 | -17 | 64 | 0 |
| TOTAL | $920,245 | $856,027 | $794,283 | $727,632 | $660,941 |
| Total Liabilities And Equity | $1,051,602 | $971,915 | $908,872 | $851,411 | $772,010 |